Sphingolipid metabolites as potential circulating biomarkers for sarcopenia in men
Abstract Background Sarcopenia is an age‐related progressive loss of muscle mass and function. Sarcopenia is a multifactorial disorder, including metabolic disturbance; therefore, metabolites may be used as circulating biomarkers for sarcopenia. We aimed to investigate potential biomarkers of sarcop...
Saved in:
| Main Authors: | Je Hyun Seo, Jung‐Min Koh, Han Jin Cho, Hanjun Kim, Young‐Sun Lee, Su Jung Kim, Pil Whan Yoon, Won Kim, Sung Jin Bae, Hong‐Kyu Kim, Hyun Ju Yoo, Seung Hun Lee |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Journal of Cachexia, Sarcopenia and Muscle |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jcsm.13582 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Carnitine Metabolite as a Potential Circulating Biomarker for Sarcopenia in Men
by: Je Hyun Seo, et al.
Published: (2025-02-01) -
Altered levels of sphingolipid metabolites in serum of locally advanced rectal cancer patients: A pilot study
by: Bjelanović Jasna, et al.
Published: (2025-01-01) -
Long non-coding RNAs-sphingolipid metabolism nexus: Potential targets for cancer treatment
by: Yan Chen, et al.
Published: (2024-12-01) -
Phospholipids and Sphingolipids in Osteoarthritis
by: Juergen Steinmeyer
Published: (2025-02-01) -
Serum and plasma sphingolipids as biomarkers of chemotherapy-induced cardiotoxicity in female patients with breast cancer
by: Samia Mohammed, et al.
Published: (2025-05-01)